Summary. The influence of six immunosuppressive agents on the occurrence of endogenous bacteraemia in mice was evaluated. The mortality rates in conventional ddY mice given cyclophosphamide (CY), fluorouracil (5-FU), methotrexate (MTX), cisplatin (CDDP) or FK-506 intraperitoneally, or dexamethasone (DXM) subcutaneously were 70, 100, 100, 100, 0 and 0 YO, respectively. Pseudomonas aeruginosa was isolated from 70 YO of mice treated with CY but from only 10% of mice treated with 5-FU and 30% treated with MTX. Enterobacteria were isolated from 90 YO of mice treated with 5-FU. Specific-pathogen-free (SPF) mice fed P. aeruginosa were also treated with these agents. All mice in the CY, 5-FU, MTX and CDDP groups died whereas mice treated with DXM and FK-506 showed 20 YO and 0 YO mortality, respectively. Pure cultures of P. aeruginosa were obtained from all of the mice treated with CY. Polymicrobial bacteraemia with P. aeruginosa and enterobacteria occurred in 5, 25, 5 and 5 % of mice treated with 5-FU, MTX, CDDP and DXM, respectively. Enterobacterial bacteraemia was observed in 70 YO of mice treated with CDDP and in 5 % of the DXM group. Different types of bacteraemia were induced by different immunosuppressive agents. The mechanism of immunosuppression may affect the frequency of bacteraemia and the causative organism.
Introduction
Bacteraemia in immunocompromised hosts frequently arises endogenously from the patient's own Pseudomonas aeruginosa, Klebsiella pneumoniae and Candida albicans are typical causes of such infections, especially in bacteraemias originating in the intestinal An animal model that resembles septicaemia in man is valuable for the evaluation of prophylaxis and treatment.
P. aeruginosa frequently causes endogenous systemic bacteraemia in leucopenic mice treated with cyclophosphamide (CY)8 and bacteraemia with specific P. aeruginosa strains can be induced by treating mice fed the organisms with CY and ampi~illin.~ These models have been used to investigate the pathogenic mechanism of endogenous bacteraemia, virulence factors and Escherichia coli, other enterobacteria and enterococci often cause portal bacteraemia only and are not isolated from cardiac
In many animal studies, CY is used to induce a compromised state. whether other immunosuppressive agents induce bacteraemia or other infections in animals, nor is it clear if P. aeruginosa bacteraemia can be induced by other immunosuppressive agents.
Six immunosuppressive agents were administered to conventional mice and specific-pathogen-free (SPF) mice fed P. aeruginosa strain D4 to compare mortality rates, frequency of occurrence of bacteraemia and causative organisms.
Materials and methods

Reagents
Sodium ampicillin (Viccillin ; Meiji Seika Kaisha Ltd, Tokyo, Japan), cyclophosphamide (CY) (Endoxan; Shionogi and Co. Ltd, Osaka, Japan), fluorouracil (5-FU) (Kyowa Co. Ltd, Tokyo), cisplatin (CDDP) (Randa Inj. ; Japan Chemical Co. Ltd, Tokyo), and dexamethasone (DXM) (Wako Pure Chemical Industries, Tokyo) were purchased from commercial sources. Methotrexate (MTX) and FK-506 were kindly provided by Lederle Japan Co. Ltd, Tokyo, and Fujisawa Pharmaceutical Co. Ltd, Tokyo respectively.
Mice
Conventional and SPF male ddY mice (Japan S.L.C. Co. Ltd, Shizuoka, Japan) weighing 20-24 g were used in the experiments. Mice were fed a sterile diet and were given sterile distilled water except during the period of oral administration of the bacteria.
Bacterial strain and media P. aeruginosa strain D4 was isolated from cardiac blood of a mouse with systemic bacteraemia induced by CY as described previously.' The organism was grown on Trypticase Soy Agar (BBL Microbiology Systems, Cockeysville, MD, USA) at 37°C for 18 h. Bacteria were suspended in sterile saline 0.45% and adjusted to lo7 cfu/ml by spectrophotometry (UVIDEC-40 ; Jasco, Tokyo).
Determination of endogenous bacteraemia
Normal conven t ional mice. Endogenous bac teraemia was induced as described previously,' with some modifications. Groups of 10 mice received ampicillin 200 mg/kg/day intraperitoneally for 15 days. Simultaneously, immunosuppressive agents were administered as follows : CY, 5-FU or MTX 200 mg/kg/day ; FK-506 100 mg/kg/day; CDDP 20 mg/kg every other day. DXM 10 mg/kg was given subcutaneously every other day.
Mice were observed four times each day and the number of deaths was recorded up to day 15. Cultures from cardiac blood were performed immediately after death. Survivors were killed by cervical dislocation and cultures were done at the end of the experiments. All samples were cultured immediately aerobically on sheep blood 5 % agar (Nissui Pharmaceutical Co. Ltd, Tokyo) and trypticase soy agar at 37°C in humidified air for 24 h. The isolates were identified by Vitek Identification Cards (Vitek Systems, Inc., Hazelwood, MO, USA). SPF mice fed P. aeruginosa 0 4 . Faecal specimens from SPF mice were obtained before the study and examined to confirm the absence of P. aeruginosa. Mice were fed P. aeruginosa D4 in drinking water for 4 days and also received ampicillin 200 mg/kg/day during this period to disrupt the balance of the normal gastro-intestinal flora. Each immunosuppressive agent was administered on days 5, 7, 9 and 1 1 as described above. Mice were monitored until day 15 and cultures of samples and identification of bacterial isolates were performed as described above.
Results
Survival of mice treated with immunosuppressive agents
Conventional mice. Mice treated with CY began to die on day 6 and their final mortality rate was 70 YO. Mice treated with CDDP also started to die on day 6 and by day 8 all had died. Mice treated with 5-FU or MTX began to die later, but all mice died within the 15 days. In contrast, none of the mice treated with DXM or FK-506 died ( fig. 1) .
SPF mice fed P. aeruginosa 0 4 . Mice treated with A, CDDP; 0, DXM; ., FK-506. 
Organism isolated from cardiac blood
Conventional mice. P . aeruginosa strains were isolated from seven, one and three mice treated with CY, 5-FU and MTX, respectively. Enterobacteria were isolated from nine, six and six mice treated with 5-FU, MTX, CDDP ( fig. 3) . Table I shows the species of enterobacteria isolated from these mice. Klebsiella spp. were the commonest cause of endogenous bacteraemia in mice treated with 5-FU or MTX. No bacteria were isolated from 10% of mice in the MTX group nor from 40% treated with CDDP. Amongst mice killed after 15 days, Morganella morganii was isolated from (table 11) . Enterobacterial bacteraemia without P. aeruginosa was observed in 70 and 5 % of mice treated with CDDP and DXM (table 111). M . morganii and Pr. mirabilis were isolated more frequently from CDDPtreated mice. Only one mouse each in the groups treated with 5-FU, CDDP and DXM and dying before day 15 remained free of bacteraemia ( fig. 4) .
Discussion
K. pneurnoniae, E. coli and P. aeruginosa are frequently involved in nosocomial ~epticaemia.~> l 9 Several outbreaks of infections including septicaemia by multi-resistant K. pneumoniae strains have been rep~rted.~. 20, 21 Epidemiological investigations have revealed that the reservoir for K. pneumoniae is the patients gastro-intestinal
We have reported previously that CY often induces bacteraemia due to endogenous P. aeruginosa in mice.8 Moreover, bacteraemia with specific P. aeruginosa strains was induced by administering CY and ampicillin to mice fed the organi~m.~ These animal models are useful for the investigation of the pathophysiology of endogenous bacteraemia, virulence factors of P. aeruginosa, and therapeutic interventi0ns.~7
Collins et al.14 and Opal et aZ.15 described a model of endogenous P. aeruginosa bacteraemia in rats for the evaluation of antibiotic treatments and immunotherapy. Unlike most models of infection, which employ intraperitoneal or intravenous routes of infection, these models incorporated other steps, such as bacterial colonisation, overgrowth and invasion. Consequently, they closely mimic the pathophysiology of septicaemia in man.', ' ' 9 l 4 Enterobacteria such as K. pneumoniae and E. coli often cause only portal bacteraemia in CY-treated mice because they are easily cleared from blood by the reticulo-endothelial system, especially by Kupffer cells in the liver.8' l 3 Therefore, suitable immunosuppressive agents other than CY should be used to establish a model of endogenous bacteraemia due to enterobacteria. Braude et a1. 22 and Ziegler et al.23 induced endogenous bacteraemia by feeding E. coli and K. pneumoniae to coliform-free rabbits conditioned with nitrogen mustard and inserting a temperature probe into the rectum. These animal models resemble the overwhelming septic shock observed after pelvic instrumentation. However, it is difficult to perform experiments with sufficient numbers of animals because of the size and cost of rabbits.
In this study, significant differences in mortality rates, frequency of bacteraemia and causative organisms were observed among mice treated with various immunosuppressive agents. CY frequently induced P. aeruginosa bacteraemia in both conventional mice and SPF mice fed P. aeruginosa D4. In contrast, CDDP often caused enterobacterial bacteraemia but mice treated with CDDP frequently died without bacteraemia, suggesting that the dose employed killed mice by acute toxicity before bacteraemia developed. DXM and FK-506 seldom induced bacteraemia. These immunosuppressive agents may not provide suitable models of endogenous bacteraemia. 5-FU induced different types of bacteraemia in conventional and SPF mice fed P. aeruginosa D4. Conventional mice frequently suffered septicaemia due to enterobacteria whereas SPF mice fed P. aeruginosa frequently suffered P. aeruginosa bacteraemia. This may be due to the difference in concentration of P. aeruginosa in the intestinal tracts of these mice. CY may induce P. aeruginosa bacteraemia selectively even when the concentration of P. aeruginosa is relatively low. The ability of MTX to induce bacteraemia was intermediate between CY and 5-FU.
The mechanisms of these differences are still to be clarified, but variation in target cells, degree of mucosal damage and the resident intestinal flora may account for the findings. The results may lead to the establishment of a new model of endogenous bacteraemia since immunosuppressive agents seem to be capable of selecting for certain bacteraemias.
